Neuroprotection Market Global Scenario Market Size, Outlook, Trend and Forecast, 2016 – 2025 - PowerPoint PPT Presentation

About This Presentation
Title:

Neuroprotection Market Global Scenario Market Size, Outlook, Trend and Forecast, 2016 – 2025

Description:

Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underlying neurodegenerative diseases. They prevent or delay the onset or the progression of neurodegenerative diseases. – PowerPoint PPT presentation

Number of Views:25
Slides: 13
Provided by: Username withheld or not provided
Category: Other

less

Transcript and Presenter's Notes

Title: Neuroprotection Market Global Scenario Market Size, Outlook, Trend and Forecast, 2016 – 2025


1
Neuroprotection Market Global Scenario Market
Size, Outlook, Trend and Forecast, 2016 2025
  • Bhavana Patel
  • SEO Analyst
  • help_at_variantmarketresearch.com

2
Neuroprotection Market
  • Neuroprotection is defined as an involvement able
    to affect the etiology or the pathogenesis
    underlying neurodegenerative diseases. They
    prevent or delay the onset or the progression of
    neurodegenerative diseases. The neuroprotective
    agents play a significant role in the management
    of neuro-degenerative disorders along with the
    central nervous system trauma, cerebral ischemia,
    and many other neuro conditions. Apart from this,
    researchers are looking ways to protect the body
    from acute events including nervous system
    damage, traumatic brains injury, spinal cord
    injury and stroke, and to help with chronic
    diseases such as Parkinsons, Alzheimers, and
    multiple sclerosis.
  • Download Free Sample Copy of Report _at_
    https//www.variantmarketresearch.com/report-categ
    ories/pharmaceuticals/neuroprotection-market/sampl
    e-request

3
Neuroprotection Market
4
Neuroprotection Market
  • Rapidly growing pharmaceutical sector, increasing
    occurrences of traumatic brain injury, and
    increasing patient population are the major
    factors driving the growth of the neuroprotection
    market. However, high cost of these treatments
    may hinder the growth of the market. Moreover,
    investment in research and development, and
    increasing drug discovery product launch is
    expected to unfold attractive growth
    opportunities in the coming future.
  • The global neuroprotection market is mainly
    classified on the basis of product, application,
    and geography. The product segment is bifurcated
    into free anti-inflammatory agents, radical
    trapping agents (antioxidants), apoptosis
    inhibitors, glutamate antagonists
    (anti-excitotoxic agents), neurotrophic factors
    (NTFs), stimulants, metal ion chelators, and
    other products. Furthermore, the application
    segment includes prevention, and treatment.
  • Browse the Complete Report _at_ https//www.variantma
    rketresearch.com/report-categories/pharmaceuticals
    /neuroprotection-market

5
Neuroprotection Market
6
Top Key Players
  • F. Hoffmann-La Roche AG
  • Eli Lilly and Company
  • Daiichi Sankyo Company
  • Allergan plc
  • Novartis AG
  • AstraZeneca plc
  • Dr. Reddy's Laboratories Ltd.
  • Astrocyte Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd., and Biogen
    Inc., among others.

7
The key takeaways from the report
  • The report will provide detailed analysis of
    Global Neuroprotection Market with respect to
    major segments such as product, application, and
    geography
  • The report will include the qualitative and
    quantitative analysis with market estimation over
    2016 2025 and compound annual growth rate
    (CAGR) between 2017 and 2025
  • Comprehensive analysis of market dynamics
    including factors and opportunities will be
    provided in the report
  • An exhaustive regional analysis of Global
    Neuroprotection Market has been included in the
    report
  • Profile of the key players in the Global
    Neuroprotection Market will be provided, which
    include key financials, product services, new
    developments and business strategies

8
Scope of the Global Neuroprotection Market
  • Product Segments
  • Free Anti-Inflammatory Agents
  • Radical Trapping Agents (Antioxidants)
  • Apoptosis Inhibitors
  • Glutamate Antagonists (Anti-Excitotoxic Agents)
  • Neurotrophic Factors (NTFs)
  • Stimulants
  • Metal Ion Chelators
  • Other Products
  • Application Segments
  • Prevention
  • Treatment

9
Scope of the Global Neuroprotection Market
  • Geographical Segments
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Russia
  • Germany
  • France
  • Italy
  • Rest of Europe

10
Scope of the Global Neuroprotection Market
  • Geographical Segments
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
  • RoW
  • South America
  • Middle East
  • Africa

11
Contact Us
  • John Dave,
  • Head - Sales
  • Variant Market Research
  • 649 Mission St, 5th Floor, San Francisco, CA
    94105, United States.
  • Tel 1-415-680-2785
  • Fax 1-415-680-2786
  • Email john.dave_at_variantmarketresearch.com
  • Email help_at_variantmarketresearch.com

12
Thank You..
Write a Comment
User Comments (0)
About PowerShow.com